{"id":"W4389449318","doi":"10.1212/wnl.96.15_supplement.2329","title":"Long Term Efficacy Outcomes with Inebilizumab Treatment in NMOSD: the N-MOmentum Trial (2329)","year":2021,"lang":"en","type":"article","venue":"Neurology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Medicine; Term (time); Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001088982,0.0005710098,0.001035117,0.00009713597,0.0003281235,0.0008156147,0.000405382,0.0007946274,0.002151658],"category_scores_gemma":[0.001648496,0.0001550882,0.001328905,0.0001719572,0.0004149774,0.0008921539,0.0005002465,0.001714556,0.0004168311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006261855,"about_ca_system_score_gemma":0.0006176049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001374968,"about_ca_topic_score_gemma":0.003783719,"domain_scores_codex":[0.9996327,0.0001766115,0.00002967164,0.00006476062,0.00003134111,0.00006484924],"domain_scores_gemma":[0.9993668,0.0001616983,0.0001702392,0.00005961905,0.00005359068,0.0001879812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8733467,0.002906912,0.03187869,0.001388905,0.006934802,0.0002225057,0.0001284045,0.00111781,0.004342251,0.0007956482,0.009689592,0.06724769],"study_design_scores_gemma":[0.7263669,0.09970088,0.1427963,0.0009719722,0.009988996,0.0006724034,0.0002271123,0.00173371,0.001765399,0.002100039,0.01357468,0.0001015445],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9796278,0.01194421,0.0002316322,0.001262239,0.0003566293,0.0002332724,0.002435432,0.00003351959,0.003875251],"genre_scores_gemma":[0.9908893,0.00191835,0.0004255265,0.001125742,0.0002683132,0.0003361077,0.003454147,0.00001180348,0.001570833],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002151658,"threshold_uncertainty_score":0.007198036,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02758538917827872,"score_gpt":0.2890848678025228,"score_spread":0.2614994786242441,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}